Infliximab effective in treating DADA2 deficiency in 32-year-old female patient: case report.

https://pubmed.ncbi.nlm.nih.gov/38115782

Infliximab, a tumor necrosis factor α inhibitor, was successful in treating a case of DADA2 deficiency, a recessively inherited autoinflammatory disease, in a 32-year-old female patient.